PATENT CLAIM ANALYSIS

Application Number: 16190412
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 16):
The method of  claim 11 , wherein the pharmaceutical composition is administered to the subject daily for a period of 1 to about 12 weeks.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 98.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16191204', '14757773', '14261160', '14173155', '14737115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6108028822523369
- 35 USC 102 Novelty (BERT): 0.5506683008904733
- Combined Prediction Score: 0.6047894241161506
- Mean Citation Score: 375.885366
- Max Citation Score: 384.2013
- Similarity Product: 355.4017563036204

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test